Business Description
IGEA Pharma NV
ISIN : NL0012768675
Share Class Description:
FRA:3B5: Ordinary SharesCompare
Compare
Traded in other countries / regions
IGPH.Switzerland3B5.Germany IPO Date
2019-01-15Description
IGEA Pharma NV focuses on highly controlled vegetable matrices and their industrial processing to extract cannabidiol, terpenes, polycosanol, and other valuable components and in the distribution of food supplements, functional food as well as health-tech and med-tech preventative products and devices. It offers medical testing devices and dietary supplements. The company has two reportable segments Industrial processing and distribution. The company has also developed a test to measure Free Copper II in the bloodstream. Its test includes ALZ-1 Test.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -80 | |||||
| 12-1 Month Momentum % | -98.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IGEA Pharma NV Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.029 | ||
| Beta | 0 | ||
| Volatility % | 531.12 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0.00075 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | -98.68 | ||
| 52-Week Range (€) | 0.0005 - 0.075 | ||
| Shares Outstanding (Mil) | 337.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IGEA Pharma NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IGEA Pharma NV Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
IGEA Pharma NV Frequently Asked Questions
What is IGEA Pharma NV(FRA:3B5)'s stock price today?
The current price of FRA:3B5 is €0.00. The 52 week high of FRA:3B5 is €0.08 and 52 week low is €0.00.
When is next earnings date of IGEA Pharma NV(FRA:3B5)?
The next earnings date of IGEA Pharma NV(FRA:3B5) is .
Does IGEA Pharma NV(FRA:3B5) pay dividends? If so, how much?
IGEA Pharma NV(FRA:3B5) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers